Table 3.
Red blood cell membrane fatty acid composition of normo- and dyslipidemic men at baseline (t0) and after supplementation with fish oil over twelve weeks (t12)
| Normolipidemic (n = 9) | Dyslipidemic (n = 7) | |||
|---|---|---|---|---|
|
Fatty acid [%]* |
t0 |
t12 |
t0 |
t12 |
| C20:4n-6 (AA) |
16.04 ± 0.80 a |
13.09 ± 0.63 # |
12.71 ± 2.52 a |
11.56 ± 1.58 |
| C20:5n-3 (EPA) |
0.85 ± 0.20 |
3.85 ± 0.64 # |
1.02 ± 0.43 |
3.46 ± 0.68 # |
| C22:6n-3 (DHA) |
4.47 ± 0.67 |
6.92 ± 0.81 # |
3.85 ± 1.45 |
6.46 ± 0.77 # |
| SFA |
36.42 ± 1.46 |
39.24 ± 1.25 # |
36.74 ± 1.78 |
39.24 ± 1.74 |
| MUFA |
17.98 ± 1.64 a |
17.20 ± 1.02 b |
22.15 ± 3.44 a |
19.03 ± 1.18 b# |
| PUFA |
44.59 ± 2.37 a |
42.98 ± 1.16 # |
40.13 ± 2.90 a |
41.11 ± 1.71 |
| n-3 PUFA |
7.90 ± 0.94 |
14.71 ± 1.45 # |
7.33 ± 2.04 |
13.53 ± 1.49 # |
| n-6 PUFA |
36.68 ± 2.09 a |
28.27 ± 1.39 # |
32.80 ± 2.04 a |
27.58 ± 1.86 # |
| Omega-3 index | 5.32 ± 0.74 | 10.77 ± 1.10 # | 4.87 ± 1.83 | 9.92 ± 1.34 # |
* percentage of total fatty acids.
a t0 values of normolipidemic subjects vs. t0 values of dyslipidemic subjects were tested by student’s t-test; p < 0.05.
b t12 values of normolipidemic subjects vs. t12 values of dyslipidemic subjects were tested by student’s t-test; p < 0.05.
# t0 values vs. t12 values were tested by student’s paired t-test; p < 0.05.